- Home
- ELTK vs BYSI Comparison
ELTK vs BYSI Comparison
Compare ELTK & BYSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- BYSI
- Stock Information
- Founded
- ELTK 1970
- BYSI 2010
- Country
- ELTK Israel
- BYSI United States
- Employees
- ELTK N/A
- BYSI N/A
- Industry
- ELTK Electrical Products
- BYSI Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- BYSI Health Care
- Exchange
- ELTK Nasdaq
- BYSI Nasdaq
- Market Cap
- ELTK 76.9M
- BYSI 79.0M
- IPO Year
- ELTK 1997
- BYSI 2017
- Fundamental
- Price
- ELTK $8.62
- BYSI $1.91
- Analyst Decision
- ELTK
- BYSI
- Analyst Count
- ELTK 0
- BYSI 0
- Target Price
- ELTK N/A
- BYSI N/A
- AVG Volume (30 Days)
- ELTK 4.1K
- BYSI 22.1K
- Earning Date
- ELTK 11-18-2025
- BYSI 11-12-2025
- Dividend Yield
- ELTK 2.32%
- BYSI N/A
- EPS Growth
- ELTK N/A
- BYSI N/A
- EPS
- ELTK 0.17
- BYSI N/A
- Revenue
- ELTK $49,310,000.00
- BYSI N/A
- Revenue This Year
- ELTK $18.60
- BYSI N/A
- Revenue Next Year
- ELTK $9.04
- BYSI N/A
- P/E Ratio
- ELTK $49.99
- BYSI N/A
- Revenue Growth
- ELTK 2.54
- BYSI N/A
- 52 Week Low
- ELTK $7.65
- BYSI $0.98
- 52 Week High
- ELTK $12.19
- BYSI $3.44
- Technical
- Relative Strength Index (RSI)
- ELTK 15.43
- BYSI 51.80
- Support Level
- ELTK $8.55
- BYSI $1.70
- Resistance Level
- ELTK $11.59
- BYSI $2.17
- Average True Range (ATR)
- ELTK 0.32
- BYSI 0.19
- MACD
- ELTK -0.41
- BYSI -0.02
- Stochastic Oscillator
- ELTK 0.00
- BYSI 56.86
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnect, flex-rigid and multi-layered boards. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About BYSI BeyondSpring Inc.
BeyondSpring Inc is engaged in clinical-stage biopharmaceutical activities focused on the development of cancer therapies. It is also focused on including immuno-oncology agents. It operates in Plinabulin pipeline segment.